Segment 3: Novel Targets and Agents in Lung Cancer

imedex has 1334 videos Subscribe Here

Description: Three renowned experts in the field of lung cancer, Dr. Mark Kris from MSKCC and Drs. Lecia Sequist and Alice Shaw from Harvard Medical School, join Dr. Jim Epstein to discuss the different molecular aberrations contributing to the pathogenesis and progression of NSCLC as they provide insights into the importance of testing for these abnormalities and the impact that results will have on treatment decisions and outcomes.

In this segment of the DocTalk: Opinion Leader Workshop in Non-Small Cell Lung Cancer, Dr. Mark G. Kris discusses the novel targets and agents in lung cancer.

Earn accreditation for this activity at the following location:

© 2014 Imedex, LLC.
Shared By : imedex
Posted on : 04/03/14
Added : 5 years ago